Studies on the impact of modifications at the Gln-Trp site in RM2-based GRPR ligands
Abstract Background One of the most studied, and preclinically as well as clinically applied gastrin-releasing peptide receptor (GRPR) ligands represents the antagonist RM2 (DOTA-Pip5-D-Phe6-Gln7-Trp8-Ala9-Val10-Gly11-His12-Sta13-Leu14-NH2). As an improved in vivo stability was observed for a RM2 an...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SpringerOpen
2025-09-01
|
| Saila: | EJNMMI Research |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1186/s13550-025-01241-7 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|